Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Paprotrain
125
CHF
CHF 125.00
In stock
AG-CR1-3504-M0011 mgCHF 125.00
Product Details | |
---|---|
Synonyms | (Z)-α-(3-Pyridinylmethylene)-1H-indole-3-acetonitrile |
Product Type | Chemical |
Properties | |
Formula |
C16H11N3 |
MW | 245.3 |
CAS | 57046-73-8 |
Purity Chemicals | ≥98% (NMR) |
Appearance | Yellow solid. |
Solubility | Soluble in DMSO (at least 5 mg/ml). |
InChi Key | YMYYQRZCCKBFBE-MDWZMJQESA-N |
Smiles | [H]\C(=C(\C#N)C1=CNC2=C1C=CC=C2)C1=CN=CC=C1 |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Protect from light. |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Cell permeable and reversible kinesin-specific MKLP-2 (mitotic kinesin-like protein 2) inhibitor [1].
- Inhibits the recruitment of the chromosome passenger proteins survivin and aurora B to the central spindle during anaphase chromosome segregation [1].
- Moderate DYRK1A inhibitor (IC50= 5.5 μM). Lead compound [3].
Product References
- Relocation of Aurora B and Survivin from Centromeres to the Central Spindle Impaired by a Kinesin-Specific MKLP-2 Inhibitor: S. Tcherniuk, et al.; Angew. Chem. (Int'l Ed.) 49, 8228 (2010)
- New MKLP-2 inhibitors in the paprotrain series: Design, synthesis and biological evaluations: C. Labrière, et al.; Bioorg. Med. Chem. 24, 721 (2016)
- Further investigation of paprotrain: Towards the conception of selective and multi-targeted CNS kinase inhibitors: C. Labrière, et al.; Eur. J. Med. Chem. 124, 920 (2016)